Source:http://linkedlifedata.com/resource/pubmed/id/15339752
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2004-9-1
|
| pubmed:abstractText |
Because small increments in levels of endogenous plasma estradiol are associated with higher postmenopausal bone mineral density, we investigated the safety and effectiveness in preventing bone loss of unopposed, very-low-dose transdermal estradiol for postmenopausal women.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0029-7844
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
104
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
443-51
|
| pubmed:dateRevised |
2009-10-26
|
| pubmed:meshHeading |
pubmed-meshheading:15339752-Administration, Cutaneous,
pubmed-meshheading:15339752-Aged,
pubmed-meshheading:15339752-Bone Density,
pubmed-meshheading:15339752-Double-Blind Method,
pubmed-meshheading:15339752-Estradiol,
pubmed-meshheading:15339752-Female,
pubmed-meshheading:15339752-Follow-Up Studies,
pubmed-meshheading:15339752-Hormone Replacement Therapy,
pubmed-meshheading:15339752-Humans
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.
|
| pubmed:affiliation |
Division of Research, Kaiser Permanente Medical Care Program, Oakland, California, USA.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|